Cause of death, by non-communicable diseases, ages 60+ in South Asia (IDA & IBRD)
South Asia (IDA & IBRD): Cause of death, by non-communicable diseases, ages 60+ was 55.4% in 2021. ▬ Flat
Cause of death, by non-communicable diseases, ages 60+ in South Asia (IDA & IBRD), 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total deaths ages 60+.
Analysis
The most recent figure for cause of death, by non-communicable diseases, ages 60+ in South Asia (IDA & IBRD) is 55.4%, measured in 2021. That is the lowest value across all 6 years on record.
The figure is down 23.4% on the previous year and down 23.9% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 60+ in South Asia (IDA & IBRD) peaked at 79.5% in 2019 and was at its lowest, 55.4%, in 2021.
South Asia (IDA & IBRD) ranks 46th of 47 groups on this measure, in the bottom quarter.
Cause of death, by non-communicable diseases, ages 60+ in South Asia (IDA & IBRD), year by year
| Year | % of total deaths ages 60+ | Change |
|---|---|---|
| 2000 | 64.7% | — |
| 2010 | 72.8% | +12.5% |
| 2015 | 76.8% | +5.4% |
| 2019 | 79.5% | +3.5% |
| 2020 | 72.3% | -9.0% |
| 2021 | 55.4% | -23.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 64.7% | 64.7% | 64.7% | 1 |
| 2010s | 76.3% | 72.8% | 79.5% | 3 |
| 2020s | 63.8% | 55.4% | 72.3% | 2 |
Countries ranked near South Asia (IDA & IBRD)
- 43 Saudi Arabia 80.8% compare
- 44 Morocco 80.6% compare
- 45 Luxembourg 80.6% compare
- 46 United States 80.6% compare
- 47 Hungary 80.4% compare
- 48 United Kingdom 80.0% compare
- 49 Kiribati 79.9% compare
More health data for South Asia (IDA & IBRD)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per capita 0.0406 units per person (2025)
- Population ages 50-54, female, annual growth rate 2.35 % change on previous year (2025)
- Population ages 45-49, male, per capita 0.0305 units per person (2025)
- Population ages 45-49, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, male, annual growth rate -1.31 % change on previous year (2025)
- Population ages 45-49, male, annual growth rate 2.55 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.029 units per person (2025)
- Population ages 40-44, male, annual growth rate 2.39 % change on previous year (2025)
- Population ages 10-14, male, per capita 0.0444 units per person (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 60+ in South Asia (IDA & IBRD)?
- Cause of death, by non-communicable diseases, ages 60+ in South Asia (IDA & IBRD) was 55.4% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 60+ recorded in South Asia (IDA & IBRD)?
- The highest recorded value was 79.5% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 60+ recorded in South Asia (IDA & IBRD)?
- The lowest recorded value was 55.4% in 2021.
- How does South Asia (IDA & IBRD) rank for cause of death, by non-communicable diseases, ages 60+?
- South Asia (IDA & IBRD) ranks 46th out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, ages 60+ rising or falling in South Asia (IDA & IBRD)?
- Over the last ten years it is down 23.9%. The long-run trend across the full record is flat.
- Where does this South Asia (IDA & IBRD) data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 60+ (% of total deaths ages 60+). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of deaths ages 60+ due to non-communicable diseases divided by number of all deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.